Baudax Bio Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2022	2021	2020	2019
Market Capitalization	0	2	19	27	65
Market Cap Growth	-	-91.41%	-30.17%	-59.41%	-
Enterprise Value	8	4	11	5	48
PE Ratio	0.00	-0.03	-0.94	-0.35	-2.01
PS Ratio	0.26	1.25	17.14	53.76	-
PB Ratio	-0.25	-0.07	1.40	-1.79	-3.90
P/FCF Ratio	-0.56	-0.06	-0.37	-0.59	-1.27
P/OCF Ratio	-0.56	-0.06	-0.38	-0.60	-1.30
EV/Sales Ratio	25.21	3.36	10.32	10.77	-
EV/EBITDA Ratio	-1.49	-0.08	-0.66	-0.07	-1.51
EV/EBIT Ratio	-1.44	-0.07	-0.56	-0.07	-1.48
EV/FCF Ratio	-2.22	-0.15	-0.23	-0.12	-0.94
Debt / Equity Ratio	-0.79	-0.33	0.65	-0.62	-0.05
Debt / EBITDA Ratio	-1.17	-0.14	-0.50	-0.13	-0.02
Debt / FCF Ratio	-1.74	-0.29	-0.17	-0.20	-0.02
Quick Ratio	0.02	0.25	1.05	1.68	2.30
Current Ratio	0.07	0.30	1.50	2.03	2.61
Asset Turnover	0.02	0.04	0.02	0.01	0
Interest Coverage	-	-	-	-55.00	-
Return on Equity (ROE)	54.50%	789.00%	605.10%	196.00%	76.50%
Return on Assets (ROA)	-48.50%	-200.70%	-30.00%	-108.80%	-73.00%
Return on Capital (ROIC)	1138.11%	365.37%	-240.73%	988.26%	295.17%
Earnings Yield	-8951.00%	-3697.11%	-106.83%	-287.16%	-49.86%
FCF Yield	-5813.46%	-1748.92%	-267.34%	-168.66%	-78.92%
Buyback Yield / Dilution	-2601.40%	-505.82%	-311.07%	-99.37%	-
Total Shareholder Return	-2601.40%	-505.82%	-311.07%	-99.37%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).